Ignite Creation Date:
2024-05-06 @ 9:15 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02935335
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2016-10-14
Brief Title:
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
Relationship Between antimüllerian Hormone Measured by a Fully Automated Assay and the Initial Dose of HP-hMG Menopur Prescribed for Infertile Women Undergoing Their First IVFICSI Cycle
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AME
Brief Summary:
AME is a non-interventional prospective longitudinal and multicenter study This study aims to measure the relationship between antimüllerian hormone serum level AMH as measured by a fully automated assay and the initial dose of Menopur HP-hMG 600 IUmL prescribed for infertile women undergoing their first IVFICSI cycle in the current practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None